Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds77 LatestBlue J$176M Series E Wednesday, November 11

Legapass

Legapass develops AML/CFT workflow and asset-identification tools that help French regulated professionals conduct due-diligence checks, screen risk sources, document evidence, and prepare estate inventories.

Libryo

Legal register and regulatory change tracking for EHS.

Legapass vs Libryo

At a Glance

DetailLegapassLibryo
CategoryCompliance & PrivacyCompliance & Privacy
Total raisedNot disclosed$1.9M
Rounds trackedNot disclosed1
Latest roundNot disclosedUndisclosed, $1.9M · May 2021
Last valuationNot disclosedNot disclosed
Lead investorsNot disclosedFuture Energy Ventures
Built forNot disclosedNot disclosed
HeadquartersNot disclosedUnited Kingdom

Funding, Side by Side

LegapassUndisclosed
Libryo$1.9M
Legapass rounds

No public rounds tracked yet.

Libryo rounds
  1. May 2021Undisclosed$1.9M

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Legapass or Libryo?
Libryo has raised $1.9M in disclosed funding, compared with no disclosed amount for Legapass.
What is Legapass best for?
Legapass develops AML/CFT workflow and asset-identification tools that help French regulated professionals conduct due-diligence checks, screen risk sources, document evidence, and prepare estate inventories.
What is Libryo best for?
Legal register and regulatory change tracking for EHS.

Source: Legal Tech Circle funding data, from public announcements. Updated November 11, 2026.